New York State Common Retirement Fund’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.6K Buy
+18,700
New +$77.8K ﹤0.01% 2774
2024
Q3
– Sell
-141
Closed -$206 – 3366
2024
Q2
$206 Sell
141
-10,590
-99% -$19.6K ﹤0.01% 3374
2024
Q1
$25.1K Buy
10,731
+589
+6% +$1.14K ﹤0.01% 3119
2023
Q4
$20.5K Sell
10,142
-23
-0.2% -$96 ﹤0.01% 3153
2023
Q3
$49.2K Buy
10,165
+48
+0.5% +$279 ﹤0.01% 3029
2023
Q2
$69.2K Hold
10,117
– – ﹤0.01% 3057
2023
Q1
$73.2K Hold
10,117
– – ﹤0.01% 2899
2022
Q4
$130K Sell
10,117
-5
-0% -$65 ﹤0.01% 2886
2022
Q3
$143K Buy
10,122
+122
+1% +$1.6K ﹤0.01% 2899
2022
Q2
$123K Buy
+10,000
New +$149K ﹤0.01% 2994

Other funds holding WHWK

New York State Common Retirement Fund's WHWK Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 18,700 shares worth $85.6K. The stake represents ﹤0.01% of the portfolio and ranks #2774 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in WHWK as recently as Q2 2024.

New York State Common Retirement Fund first reported a position in WHWK in Q2 2022 and has held it in 10 quarters since. The position peaked at $143K in Q3 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • New York State Common Retirement Fund held 18,700 shares of Whitehawk Therapeutics worth $85.6K as of Q2 2026.
  • Whitehawk Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2774 holding.
  • New York State Common Retirement Fund first reported a position in Whitehawk Therapeutics in Q2 2022 and has held it in 10 quarters since.
  • New York State Common Retirement Fund's Whitehawk Therapeutics position peaked at $143K in Q3 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.